Replies to post #173020 on Biotech Values

[ciotera]

…majority of [Sovaldi] prescriptions are for GT2 so far, followed by GT3, GT1/4.

This is to be expected in the beginning as the GT2 and GT3 warehouse gets depleted. The question is how long it'll last until it's back to business as usual. Overall for the year, I still expect at least 40% of the business to come from GT1s.